STAAR Surgical Co. Merger Agreement Filed

TL;DR

STAAR Surgical Co. is getting acquired, proxy filing confirms.

AI Summary

STAAR Surgical Company announced on August 5, 2025, that it has entered into a definitive merger agreement. This filing is a Definitive Additional Materials proxy statement related to this agreement, indicating a significant corporate event for the company.

Why It Matters

This filing signals a potential change in ownership or structure for STAAR Surgical Company, which could impact its stock price and future operations.

Risk Assessment

Risk Level: medium — Merger agreements introduce uncertainty regarding deal completion, regulatory approval, and potential changes in strategic direction.

Key Players & Entities

• STAAR Surgical Company (company) — Registrant and subject of the merger agreement
• August 5, 2025 (date) — Date of the merger agreement announcement

FAQ

Key Financial Figures

• $28.00 — r agreement to be acquired by Alcon for $28.00 per share in cash. STAAR will hold a vi
• $18.49 — ly, STAAR's common stock closed at only $18.49 per share just prior to the announcemen

Filing Documents

• d86426ddefa14a.htm (DEFA14A) — 23KB
• g86426dsp007.jpg (GRAPHIC) — 136KB
• g86426dsp008.jpg (GRAPHIC) — 77KB
• 0001193125-25-204402.txt ( ) — 318KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement between the parties to the proposed transaction or extend the anticipated timetable for completion of the proposed transaction; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possib

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law,

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, STAAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

View Full Filing

View this DEFA14A filing on SEC EDGAR